News
Stroke risk in new-onset atrial fib goes up with greater alcohol intake
That increasing risk, which is independent of oral anticoagulation, may attenuate or disappear in patients who give up drinking after their AF...
News
Are left atrial thrombi that defy preprocedure anticoagulation predictable?
Features that predispose to such persistent LA thrombi, which are not very rare, could potentially guide more targeted TEE screening before rhythm...
News
Novel rehab program fights frailty, boosts capacity in advanced HF
The program, started in the hospital, worked on capabilities such as mobility, balance, and strength that would be necessary if exercises meant to...
News
A ‘mess’ of a diagnosis: Is it type 2 MI or a nonischemic imposter?
Often tough to tell apart and with surprisingly poor prognoses, type 2 MI and nonischemic myocardial injury lack trials to guide therapy. Whether...
News
Modest clinical gain for AF screening of asymptomatic elderly: STROKESTOP
Literally all known 75- and 76-year-olds in two Swedish regions were included, whether or not they were screened by mobile ECG recorder. But does...
News
HDL anti-inflammatory effects show prognostic potential
A prospective study offers new insights to questions such as why high HDL cholesterol levels aren’t always cardioprotective.
News
Medtronic recall of almost 240,000 ICDs is class I, FDA says
The recall applies to implantable defibrillators, with and without resynchronization pacing, that are at apparent risk for premature and possibly...
News
How to convince patients muscle pain isn’t a statin Achilles heel: StatinWISE
The strategy seemed to work in this trial: two-thirds of patients who previously rejected statins, perceiving them as the cause of muscle pain,...
News
New light cast on type 2 MI aims to sharpen diagnosis, therapy
A large survey of type 2 MI, triggered when myocardial oxygen demand outstrips supply, points to confusion hindering its diagnosis and treatment...
News
FDA expands sacubitril/valsartan indication to embrace some HFpEF
The newly approved labeling for sacubitril/valsartan (Entresto) is simply for “chronic heart failure” but almost teasingly adds, “the benefits are...
News
FDA approves orphan drug evinacumab-dgnb for homozygous FH
Indicated for homozygous familial hypercholesterolemia on top of other lipid-modifying therapy, Evkeeza (Regeneron) is a first-in-class inhibitor...
News
Myocarditis by CMR may be rare after COVID-19 in elite athletes
Some supposed ‘myocarditis’ detected by MRI after COVID-19 in university varsity competitors might be normal heart muscle – normal for athletes,...
News
Biomarker HF risk score envisioned as SGLT2 inhibitor lodestar in diabetes
Together, four “easily measured” biomarkers predicted 5-year heart failure risk in patients with diabetes or prediabetes, potentially identifying...
News
Calcium burden drives CV risk whether coronary disease is obstructive or not
That future cardiovascular risk tracks closely with plaque burden, but not so much with whether the coronary disease is obstructive, may never...